Ozaki T, Nagase T, Ichimiya S, Seki N, Ohiri M, Nomura N, Takada N, Sakiyama S, Weber BL, Nakagawara A (Sep 2000). "NFBD1/KIAA0170 is a novel nuclear transcriptional transactivator with BRCT domain". DNA Cell Biol19 (8): 475–485. PMID10975465. doi:10.1089/10445490050128403.
de Jager M, van Noort J, van Gent DC, Dekker C, Kanaar R, Wyman C (Nov 2001). "Human Rad50/Mre11 is a flexible complex that can tether DNA ends". Mol Cell8 (5): 1129–1135. PMID11741547. doi:10.1016/s1097-2765(01)00381-1.
Lou Z, Minter-Dykhouse K, Franco S, Gostissa M, Rivera MA, Celeste A, Manis JP, van Deursen J, Nussenzweig A, Paull TT, Alt FW, Chen J (Jan 2006). "MDC1 maintains genomic stability by participating in the amplification of ATM-dependent DNA damage signals". Mol Cell21 (2): 187–200. PMID16427009. doi:10.1016/j.molcel.2005.11.025.
Lee JH, Park SJ, Jeong SY, Kim MJ, Jun S, Lee HS, Chang IY, Lim SC, Yoon SP, Yong J, and You HJ (Apr 2015). "MicroRNA-22 Suppresses DNA Repair and Promotes Genomic Instability through Targeting of MDC1". Cancer Research75 (7): 1298–1310. PMID25627978. doi:10.1158/0008-5472.CAN-14-2783.
Bartkova J, Hořejsí Z, Sehested M, Nesland JM, Rajpert-De Meyts E, Skakkebæk NE, Stucki M, Jackson S, Lukas J, Bartek J (Jun 2007). "DNA damage response mediators MDC1 and 53BP1: constitu- tive activation and aberrant loss in breast and lung cancer, but not in testicular germ cell tumours". Oncogene26 (53): 7414–7422. PMID17546051. doi:10.1038/sj.onc.1210553.
Yang M, Bu Y, Wang C, Liu G, Song F (Sep 2010). "Growth inhibition, morphology change, and cell cycle alterations in NFBD1-depleted human esophageal cancer cells". Mol Cell Biochem342 (1–2): 1–6. PMID20364298. doi:10.1007/s11010-010-0460-3.
Yuan C, Bu Y, Wang C, Yi F, Yang Z, Huang X, Cheng L, Liu G, Wang Y, Song F (Jan 2010). "NFBD1/MDC1 is a protein of oncogenic potential in human cervical cancer". Mol Cell Biochem359 (1–2): 333–46. PMID21853275. doi:10.1007/s11010-011-1027-7.
Ozaki T, Nagase T, Ichimiya S, Seki N, Ohiri M, Nomura N, Takada N, Sakiyama S, Weber BL, Nakagawara A (Sep 2000). "NFBD1/KIAA0170 is a novel nuclear transcriptional transactivator with BRCT domain". DNA Cell Biol19 (8): 475–485. PMID10975465. doi:10.1089/10445490050128403.
de Jager M, van Noort J, van Gent DC, Dekker C, Kanaar R, Wyman C (Nov 2001). "Human Rad50/Mre11 is a flexible complex that can tether DNA ends". Mol Cell8 (5): 1129–1135. PMID11741547. doi:10.1016/s1097-2765(01)00381-1.
Lou Z, Minter-Dykhouse K, Franco S, Gostissa M, Rivera MA, Celeste A, Manis JP, van Deursen J, Nussenzweig A, Paull TT, Alt FW, Chen J (Jan 2006). "MDC1 maintains genomic stability by participating in the amplification of ATM-dependent DNA damage signals". Mol Cell21 (2): 187–200. PMID16427009. doi:10.1016/j.molcel.2005.11.025.
Lee JH, Park SJ, Jeong SY, Kim MJ, Jun S, Lee HS, Chang IY, Lim SC, Yoon SP, Yong J, and You HJ (Apr 2015). "MicroRNA-22 Suppresses DNA Repair and Promotes Genomic Instability through Targeting of MDC1". Cancer Research75 (7): 1298–1310. PMID25627978. doi:10.1158/0008-5472.CAN-14-2783.
Bartkova J, Hořejsí Z, Sehested M, Nesland JM, Rajpert-De Meyts E, Skakkebæk NE, Stucki M, Jackson S, Lukas J, Bartek J (Jun 2007). "DNA damage response mediators MDC1 and 53BP1: constitu- tive activation and aberrant loss in breast and lung cancer, but not in testicular germ cell tumours". Oncogene26 (53): 7414–7422. PMID17546051. doi:10.1038/sj.onc.1210553.
Yang M, Bu Y, Wang C, Liu G, Song F (Sep 2010). "Growth inhibition, morphology change, and cell cycle alterations in NFBD1-depleted human esophageal cancer cells". Mol Cell Biochem342 (1–2): 1–6. PMID20364298. doi:10.1007/s11010-010-0460-3.
Yuan C, Bu Y, Wang C, Yi F, Yang Z, Huang X, Cheng L, Liu G, Wang Y, Song F (Jan 2010). "NFBD1/MDC1 is a protein of oncogenic potential in human cervical cancer". Mol Cell Biochem359 (1–2): 333–46. PMID21853275. doi:10.1007/s11010-011-1027-7.